Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
- 123 Downloads
The aim of this article is to consider Bayesian and frequentist inference methods for measures of incremental cost effectiveness in data obtained via a clinical trial. The most useful measure is the cost-effectiveness (C/E) acceptability curve. Recent publications on Bayesian estimation have assumed a normal posterior distribution, which ignores uncertainty in estimated variances, and suggest unnecessarily complicated methods of computation. We present a simple Bayesian computation for the C/E acceptability curve and a simple frequentist analogue. Our approach takes account of errors in estimated variances, resulting in calculations that are based on distributions rather than normal distributions.
If inference is required about theC/E ratio,we argue that the standard frequentist procedures give unreliable or misleading inferences, and present instead a Bayesian interval.
Unable to display preview. Download preview PDF.
- 13.Jones DA. A Bayesian approach to the economic evaluation of health care technologies. In: Spiker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 1189-96Google Scholar
- 15.Bala MV, Mauskoff J. The estimation and use of confidence intervals in economic analysis. Drug Inf J 1999; 33: 841-8Google Scholar
- 16.O’Hagan A, Stevens JW, Montmartin J. Bayesian cost-effectiveness analysis from clinical trial data. Research report 489/99. Department of Probability and Statistics, University of Sheffield, Sheffield: 1999Google Scholar
- 20.Löthgren M, Zethraeus N. On the interpretation of cost-effectiveness acceptability curves. Working paper series in economics and finance. Stockholm: Stockholm School of Economics, 1999: no. 323Google Scholar
- 21.Fisher CJ, Slotman GJ, Opal SM, et al., IL-1ra Sepsis Syndrome Study Group. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994; 22: 12-21Google Scholar
- 22.Stuart A, Ord JK. Kendall’s advanced theory of statistics. Vol. 2. 5th ed. London: Arnold, 1991: example 20.4Google Scholar
- 24.Tambour M, Zethraeus N. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results. Econ Eval 1998; 7: 143-7Google Scholar
- 26.Lee PM. Bayesian statistics: an introduction. 2nd ed. London: Arnold, 1997Google Scholar